Autoimmune drug market set to nearly double to $138 billion by 2035
Positive market-size story meets balanced institutional positioning—institutions are accumulating quietly off-exchange but not aggressively tilting bullish or defensive.
What the institutional money is doing on REGN right now — dark pool, options positioning, and where the news and the money disagree. Free.
Positive market-size story meets balanced institutional positioning—institutions are accumulating quietly off-exchange but not aggressively tilting bullish or defensive.
Strong product momentum aligns with balanced hedging posture—institutions are neither rushing in nor bracing for downside, suggesting confidence without euphoria.
Sector bullishness in analyst calls does not match REGN's own money signals, which remain balanced and cautious despite the positive biotech backdrop.
Neutral, forward-looking event coverage carries no signal for current institutional positioning or near-term risk appetite.
Neutral headline (neither bullish nor bearish for REGN) aligns with REGN's balanced money posture—institutions are neither fleeing nor piling in ahead of competitive moves.
A divergence is when the news narrative and the institutional money flow point in opposite directions — a bearish headline while large call premium is bought, or heavy dark-pool selling under a bullish story. It signals the crowd and the desks may disagree.
Dark-pool volume — The share of trading done off-exchange, where institutions move size quietly. Well above ~40% means big players are active.
Max pain — The price where the most options expire worthless — positioning often gravitates toward it near expiry.
Call wall / Put floor — Strikes with the heaviest call/put open interest — they often act as short-term resistance and support.
Put/Call ratio — Below ~0.7 leans bullish (more calls); above ~1 leans defensive (more puts).